NanoViricides (NYSEMKT: NNVC)
$1.18
(0.4%)
$0.00
Price as of April 19, 2024, 10:15 a.m. ET
NanoViricides Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NanoViricides Company Info
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
News & Analysis
Featured Article
Could These 3 Biotechs Help Fight the MERS Virus?
Inovio Pharmaceuticals, Novavax, and Nanoviricides are developing treatments for the deadly MERS virus. Here’s what you need to know.
Leo Sun | May 17, 2014
Featured Article
5 of Last Week's Biggest Losers
These five stocks posted double-digit percentage declines.
Rick Munarriz | Feb 16, 2014
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.